Moving Our Nation Forward
News image

Improving Americans’ Quality of Life: Homes, Health, Jobs, and Education

Oversight Committee Democrats are focused on preserving home ownership, getting America back to work, ensuring quality, affordable health care, and giving all students access to a high-quality education.

News image

Making Government Work for All Americans

Our aggressive agenda works to root out waste, fraud and abuse in government spending, enhance transparency, and ensure that the needs of Americans are put ahead of corporate special interest.

News image

Promoting the Safety and Well-Being of the American People

We are committed to supporting our troops and veterans, protecting American consumers, and safeguarding national and homeland security.

For a PDF version of the Democratic Agenda, please click here.

PDF Print

Investigation of "Drug Speculation" by "Gray Market" Drug Companies 


In the 112th Congress, Ranking Member Elijah E. Cummings launched an investigation into why hospitals and other health care providers have difficulty obtaining short-supply prescription drugs needed to treat patients suffering from cancer and other life-threatening conditions.

The investigation resulted in a bicameral report titled “Shining Light on the Gray Market,” which exposed a network of private “gray market” companies that take advantage of the national drug shortage crisis to charge exorbitant prices for drugs used to treat cancer and other life-threatening conditions. Follow the links below to learn more about the investigation.

Five Things You Should Know:

1.  Ranking Member Cummings launched his investigation after receiving a heartfelt letter from Brenda Frese, the head women’s basketball coach at the University of Maryland, whose son was diagnosed with leukemia and treated with a drug called cytarabine, which at that time was on FDA’s shortage list.

4. The investigation found that “gray market” drug companies charge exorbitant prices for shortage drugs; that "fake pharmacies" acquire prescription drugs and sell them into the gray market; and that drugs are marked up repeatedly as they pass from owner to owner.

2. Ranking Member Cummings requested internal documents from five “gray market” companies to determine how they obtain shortage drugs, and how much they profit by selling them to hospitals, pharmacies, and health care providers.

5. Ranking Member Cummings introduced legislation to reform gray market drug sales, H.R. 5853, the "Gray Market Drug Reform and Transparency Act of 2012." The bill includes several provisions to address weaknesses in the drug supply chain, deter price gouging, and improve drug safety and efficacy.

3.   Senators Jay Rockefeller and Tom Harkin joined Ranking Member Cummings' investigation, which expanded to look at 125 different “gray market” companies and 300 separate drug transaction chains. Ranking Member Cummings was invited to present on the findings before the Senate Health, Labor and Pensions Committee. 

How a Typical Drug Chain Should Work:


What Happens In the Gray Market:


Quick Links: 

Press Clips:

    • Watch VIDEO CBS Baltimore -- Cummings Testifies on Drug Shortages on Capitol Hill
    • Read AP Story on Cummings, Rockefeller, and Harkin Investigation
    • Watch ABC World News Tonight story on "Fake Pharmacies"  
    • Watch NBC Nightly News Story on Cummings Gray Market Investigation
    • Watch CBS Evening News Story on Cummings Gray Market Investigation
    • Read AP Story -- Cummings Demands Action on Gray Market Drug Marketer

    Documents and Press Releases 

    • Read about the background of the investigation.
    • Visit the Tip Line
    • Learn about "Fake Pharmacies"
    • Read Cummings and Sen. Rockefeller's  Joint Report on “Gray Market” Drug Companies Charging Exorbitant Prices for Drugs Facing Critical National Shortages
    • Read Cummings Testifies Before Senate Commerce Committee on “Gray Market” Drug Companies Charging Exorbitant Prices for Drugs Facing Critical Shortages
    • Read Cummings's Bill to Reform “Gray Market” Drug Sales
    • Read Cummings, Rockefeller, and Harkin Investigate “Fake Pharmacies” Buying and Selling Shortage Drugs in the Gray Market
    • Read Senate Chairmen Join Cummings’ Investigation of “Gray Market” Drug Companies
    • Read Cummings Investigates “Drug Speculation” and “Gray Market” Sales ‪of Drugs in Critically Short Supply
    • Read Cummings letter from Brenda Frese


    Committee On Oversight and Government Reform

    U.S. House of Representatives | 2471 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051

    Washington DC Web Development Company for WordPress, Drupal.
Site by Govtrends